Literature DB >> 6311954

Herpes simplex virus non-structural proteins. IV. Purification of the virus-induced deoxyribonuclease and characterization of the enzyme using monoclonal antibodies.

L Banks, D J Purifoy, P F Hurst, R A Killington, K L Powell.   

Abstract

The alkaline nucleases induced by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) have been purified from high salt extracts of virus-infected cells. The purification used three types of column chromatography and resulted in apparently homogeneous DNase preparations with good recovery. The enzyme from HSV-2-infected cells has been characterized. It had both exonuclease and endonuclease activity, each with an unusually high pH optimum. The enzyme had an absolute requirement for magnesium which could not be replaced by other divalent cations. Analysis of the sedimentation characteristics and electrophoretic properties of the purified enzyme indicated that it was composed of a single subunit of mol. wt. 85 000. The purified HSV-2 enzyme was used as an immunogen to prime BALB/c mice which were used to prepare monoclonal antibodies. Three monoclonal antibodies were shown by several criteria to react with the enzyme. Thus, we were able to confirm that the 85K polypeptide did indeed have nuclease activity. This polypeptide was designated ICSP 22 in earlier studies and is a major polypeptide of virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311954     DOI: 10.1099/0022-1317-64-10-2249

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Association between the herpes simplex virus major DNA-binding protein and alkaline nuclease.

Authors:  M S Thomas; M Gao; D M Knipe; K L Powell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates.

Authors:  R Martinez; R T Sarisky; P C Weber; S K Weller
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Purification and characterization of herpes simplex virus type 1 alkaline exonuclease expressed in Escherichia coli.

Authors:  J C Bronstein; P C Weber
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  DNA-binding protein associated with herpes simplex virus DNA polymerase.

Authors:  P J Vaughan; D J Purifoy; K L Powell
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

6.  DNA sequence of the region in the genome of herpes simplex virus type 1 containing the exonuclease gene and neighbouring genes.

Authors:  D J McGeoch; A Dolan; M C Frame
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

Review 7.  Recombination promoted by DNA viruses: phage λ to herpes simplex virus.

Authors:  Sandra K Weller; James A Sawitzke
Journal:  Annu Rev Microbiol       Date:  2014-06-09       Impact factor: 15.500

8.  Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function.

Authors:  M Tisdale; P Ertl; B A Larder; D J Purifoy; G Darby; K L Powell
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Production of antibodies of predetermined specificity against herpes simplex virus DNA polymerase and their use in characterization of the enzyme.

Authors:  M S Thomas; L M Banks; D J Purifoy; K L Powell
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  The UL12 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation.

Authors:  Hikaru Fujii; Akihisa Kato; Michio Mugitani; Yukie Kashima; Masaaki Oyama; Hiroko Kozuka-Hata; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.